… The use of recombinant ACE2 protein has been proposed as a potential therapeutic approach to treat COVID-19, with the ACE2 protein acting as a decoy receptor for SARS-CoV-2 (58). …
A Latuapo, M Farid… - Systematic Reviews in …, 2020 - search.ebscohost.com
… Elements of self-reflection and introspection coping among covid19 patients in quarantine, … Elements of management using the psychology of forgiveness during the covid19 pandemic …
… for the treatment of COVID-19 patients. These drugs and therapeutic agents include antiviral … and most updated therapeutic drugs to prevent, control, and treat COVID-19 patients until …
… effective antiviral therapy (13). Currently, the unavailability of effective antiviral drug therapy in … of transmission of newly emerging COVID-19 infection. As per WHO guidelines, infection …
… prevention of the cytokines storm in severe COVID-19 patients. In this context, monoclonal antibodies block inflammatory mediators, such as IL-1β, IL-2, IL-6/IL-6R, TLR3, IL-8, IL-12/IL-…
… findings may suggest that Covid-19 infection is a nAChR … to prevent the infection and the retro-propagation of the virus through the CNS, we plan a therapeutic assay against Covid-19 …
M Tarek, A Savarino - European journal of drug metabolism and …, 2020 - Springer
… but may have more general implications for development of anti-COVID-19 combination therapies and prevention strategies through an increased death rate of the infected cells. …
MF Hossain, S Hasana, AA Mamun… - Frontiers in …, 2020 - frontiersin.org
… officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (…
L Du, Y Yang, X Zhang - Cellular & molecular immunology, 2021 - nature.com
… therapeutic target, and prevention and treatment of coronavirus disease 2019 (COVID-19) … by these nAbs play in the prevention and treatment of COVID-19 and discuss the potential to …